Journal archive · Revision and secondary rhinoplasty · 2022

Commentary on "Evidence of Biofilm and Persister Cell Formation in Revision Rhinoplasty" by Kao et al

Said M, Hom DB.

Start here

What the rhinoplasty literature says on this paper's topic, cited line by line to PubMed.

Related papers

Same topic, 2022.

1. APS
   A Modified Large-Cap Graft in East Asian Revision Rhinoplasty

   Zheng R, Dong W, Han R et al.
   2022PMID 35577970Summary
2. APS
   Disussion: A Modified Large-cap Graft in East Asian Revision Rhinoplasty

   Lin SJ, Seyidova N
   2022PMID 35817877Full text
3. APS
   Invited Discussion on: Re-evaluating the Effect of Preoperative Tranexamic Acid on Blood Loss and Field Quality During Rhinoplasty: A Randomized double-blinded controlled Trial

   Zins JE, Dutton JW
   2022PMID 34981155
4. APS
   Re-Evaluating the Effect of Preoperative Tranexamic Acid on Blood Loss and Field Quality During Rhinoplasty: A Randomized Double-Blinded Controlled Trial

   Afzali SL, Panahi H, Ganji F et al.
   2022PMID 34585263Summary
5. CPS
   Preoperative Evaluation of the Rhinoplasty Patient

   Clappier M, Tanna N
   2022PMID 34782128Summary
6. FPS
   In-office Endonasal Minor Revision Rhinoplasty

   Auger SR, Shah AR
   2022PMID 34544174Summary
7. FPSAM
   Evidence of Biofilm and Persister Cell Formation in Revision Rhinoplasty

   Kao WK, Faddis B, Chole RA et al.
   2022PMID 35724255Summary
8. PRS
   Differences between Primary and Revision Rhinoplasty: Indications, Techniques, Grafts, and Outcomes

   Wang X, Dong W, Fan F
   2022PMID 36067469